Intellipharmaceutics
is a Canada-based pharmaceutical company that researches and develops oral solid dosage drugs for the treatment of neurology and cardiovascular disorders... Read moreIntellipharmaceutics
is a Canada-based pharmaceutical company that researches and develops oral solid dosage drugs for the treatment of neurology and cardiovascular disorders... Read more
News
Jun 14, 2024
Mykmlk
Intellipharmaceutics: Intellipharmaceutics Announces Downgrade to OTC Expert Market
Mar 19, 2024
Stockwatch
Intellipharmaceutics: IntelliPharmaCeutics lists on NEX
Mar 06, 2024
8newsnow
Intellipharmaceutics: Intellipharmaceutics Announces Cease Trade Order
Feb 27, 2024
Firstwordpharma
Intellipharmaceutics: Intellipharmaceutics Announces Its Expected Delay in Filing Annual Audited Financial Statements and Annual Information Form
Feb 08, 2024
FinanzNachrichten
Intellipharmaceutics: Intellipharmaceutics International Inc. Announces Stock Option Grant
Jan 03, 2024
Firstwordpharma
Intellipharmaceutics: Intellipharmaceutics International Inc. Receives Conditional Approval to List on the TSX Venture Exchange
Oct 16, 2023
Cenlanow
Intellipharmaceutics: Intellipharmaceutics Announces Third Quarter 2023 Results
Oct 16, 2023
MarketScreener
Intellipharmaceutics: Intellipharmaceutics International : MANAGEMENT DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS FOR THE THREE AND NINE MONTHS ENDED AUGUST 31, 2023 - Form 6-K
Oct 16, 2023
Yahoo
Intellipharmaceutics: Intellipharmaceutics: Fiscal Q3 Earnings Snapshot
Jul 14, 2023
BioSpace
Intellipharmaceutics: Intellipharmaceutics Announces Second Quarter 2023 Results
Intellipharmaceutics Competitors
1
2
3
4
5
6
7
8
9
10